TOR-mediated cell-cycle activation causes neurodegeneration in a Drosophila tauopathy model

Vikram Khurana, Yiran Lu, Michelle L. Steinhilb, Sean Oldham, Joshua M. Shulman, Mel B. Feany

Research output: Contribution to journalArticlepeer-review

213 Scopus citations

Abstract

Background: Previous studies have demonstrated reexpression of cell-cycle markers within postmitotic neurons in neurodegenerative tauopathies, including Alzheimer's disease (AD). However, the critical questions of whether cell-cycle activation is causal or epiphenomenal to tau-induced neurodegeneration and which signaling pathways mediate cell-cycle activation in tauopathy remain unresolved. Results: Cell-cycle activation accompanies wild-type and mutant tau-induced neurodegeneration in Drosophila, and genetically interfering with cell-cycle progression substantially reduces neurodegeneration. Our data support a role for cell-cycle activation downstream of tau phosphorylation, directly preceding apoptosis. We accordingly show that ectopic cell-cycle activation leads to apoptosis of postmitotic neurons in vivo. As in AD, TOR (target of rapamycin kinase) activity is increased in our model and is required for neurodegeneration. TOR activation enhances tau-induced neurodegeneration in a cell cycle-dependent manner and, when ectopically activated, drives cell-cycle activation and apoptosis in postmitotic neurons. Conclusions: TOR-mediated cell-cycle activation causes neurodegeneration in a Drosophila tauopathy model, identifying TOR and the cell cycle as potential therapeutic targets in tauopathies and AD.

Original languageEnglish
Pages (from-to)230-241
Number of pages12
JournalCurrent Biology
Volume16
Issue number3
DOIs
StatePublished - Feb 7 2006

Fingerprint

Dive into the research topics of 'TOR-mediated cell-cycle activation causes neurodegeneration in a Drosophila tauopathy model'. Together they form a unique fingerprint.

Cite this